Although augmentation of mitochondrial-oriented free radical scavengers such as MCAT and SOD-2 have shown promising results in animal models of ischemic cardiomyopathy as well as hypertensive heart failure [30, 31], they have not been adequately explored in the context of sepsis. This evidence concerns the gene SOD2 and Sepsis.